TheraRadar
← All Targets

TNFα

1 drugs
Immunology
Market Leader
ZYMFENTRA
CELLTRION
2
approved indications
1
Approved Drugs
1
Companies
2
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 1 approved drugs
Therapeutic area breakdown
Full indication list (2 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

CELLTRION 1 drug

By Therapeutic Area

Immunology 1 drugs